Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005
-
* Corresponding author: Alan Tyndall alan.tyndall@fps-basel.ch
Arthritis Research & Therapy 2007, 9:301 doi:10.1186/ar2103
Accesses
- Last 30 days: 101 accesses
- Last 365 days: 1197 accesses
- All time: 7416 accesses
Cited by
BioMed Central: 2 citations
|
Niels Mensing, Hagen Gasse, Nina Hambruch, Jan-Dirk Haeger, Christiane Pfarrer, Carsten Staszyk BMC Veterinary Research 2011, 7:42 (2 August 2011) |
|
Flavio A Carrion, Fernando E Figueroa Stem Cell Research & Therapy 2011, 2:23 (11 May 2011) This article is part of a collection on Immunology and stem cells Mesenchymal stem cells have been successfully applied in patients with severe treatment-refractory systemic lupus erythematosus in uncontrolled phase I and II trials suggesting larger randomized controlled trials should be performed.
|